ETF Comparison: IBB vs VHT
ETF 說明
IBB - iShares Biotechnology ETF
The iShares Biotechnology ETF provides exposure to the biotechnology sub-sector of the health care industry, investing in a diversified portfolio of over 200 stocks. The fund focuses on U.S. biotechnology companies, with a smaller allocation to international firms, and employs a tiered weighting scheme. It offers a multi-cap approach, investing in large, mid, and small-cap stocks, making it a comprehensive option for investors seeking biotech exposure.
VHT - Vanguard Health Care ETF
The Vanguard Health Care ETF provides exposure to the US health care sector, offering a diversified portfolio of over 400 stocks with a low expense ratio. The fund tracks the MSCI US IMI 25/50 Health Care Index, providing a broad-based investment in the health care industry. With a large-cap focus, VHT is suitable for investors seeking long-term growth in the US health care sector.
比較表
| IBB | VHT | |
|---|---|---|
| 基金名稱 | iShares Biotechnology ETF | Vanguard Health Care ETF |
| Fund Provider | BlackRock | Vanguard |
| Index | ICE Biotechnology Index | MSCI US IMI 25/50 Health Care |
| Asset Class | Equity | Equity |
| Listing | US-listed | US-listed |
| Expense Ratio | 0.45% | 0.10% |
| Inception Date | 2001-02-05 | 2004-01-26 |
| Number Of Holdings | 211 | 421 |
| Currency | USD | USD |
| Region | United States | United States |
| Investment Style | Growth | Growth |
| Market Cap | Blend | Large-Cap |
| Sector | Healthcare | Healthcare |
| Sector Detail | Biotechnology | Health Care |
| Leveraged | Non-leveraged | Non-leveraged |
回測選項
摘要
關鍵指標
績效指標
風險指標
詳細報酬
績效分析
績效分析透過累積報酬、年底（EoY）報酬及 Sharpe 比率、Sortino 比率等風險調整指標，評估歷史資料以衡量投資策略報酬。這有助於投資人在不同市場條件下評估絕對和相對績效。
累積報酬
年底報酬表
年底報酬
風險分析
風險分析是指對可能導致資本損失的潛在負面事件進行評估。進行風險分析有助於決定是否應進行投資。這是透過回撤、波動率和 Beta 等風險指標來完成的，這些指標反映了利益相關者對投資策略一致性的信心。
回撤
回撤表
Monte Carlo 模擬
Monte Carlo 模擬是一種統計方法，透過從歷史資產價格資料中隨機抽樣產生大量潛在結果，用以預測投資組合報酬。它協助投資人評估各種市場條件下投資組合的潛在風險和報酬。模擬考慮初始投資，並可選擇性地模擬現金流情境，如固定投入、固定提款或比例提款。
重要提示：透過 Monte Carlo 模擬產生的預測純屬假設性質，不保證未來報酬。投資決策應考量多種因素，過去表現不代表未來結果。